Miniature power reshapes cardiac monitoring

Ilika Plc

Implantable devices are entering a phase where design freedom depends more on power. The latest solid state batteries are changing that equation, enabling devices small enough to disappear inside the body yet strong enough to run continuous cardiac monitoring. What matters is not a bigger cell but one that is safer, rechargeable, and efficient enough to support constant data flow between patient and clinician.

Cardiac monitors have long faced the same constraint, continuous sensing drains batteries too fast. The result has been limited data or frequent replacements. A new generation of millimetre scale solid state batteries is removing that trade off. With a footprint of roughly 5.6 by 3.6 millimetres and a depth close to one millimetre, these batteries fit inside minimally invasive devices. Their 300 microamp hour capacity, combined with high pulse capability, supports telemetry and alerts without overheating or leakage.

Instead of replacing entire devices, clinicians can recharge them wirelessly, avoiding repeat surgeries and extending product life. Faster charging makes home recharging practical, improving patient compliance and cutting hospital time. The rectangular form fits standard electronics layouts, while long cycle life keeps devices in service for years. Manufacturers can now build smaller, smarter implants without compromising reliability or power delivery.

Continuous rhythm monitoring captures irregular heartbeats, short episodes of atrial fibrillation and brief cardiac pauses that would otherwise go unnoticed. More consistent data improves diagnostic accuracy and enables machine learning systems to flag only meaningful anomalies. This efficiency strengthens the economics of remote care by reducing hospital admissions and allowing earlier intervention. Smaller batteries also make implants easier to place, shorten recovery times, and reduce procedural risks, all of which align with hospital incentives to shift towards outpatient care.

Ilika plc (LON:IKA) is a pioneer in solid state battery technology enabling solutions for applications in Industrial IoT, MedTech, Electric Vehicles and Consumer Electronics.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Ilika builds the manufacturing path for Goliath solid-state batteries

Ilika is building the manufacturing and licensing pathway needed to move its Goliath solid-state battery technology towards larger-scale commercial production.

Ilika: Stereax revenue growth and Goliath opportunities ahead

Morphose Capital Partners’ Dr Tom McColm discusses Ilika’s FY26 results, the outlook for Stereax commercial revenues, progress with Goliath and potential opportunities in automotive, defence and e-bikes.

Ilika CEO highlights Stereax revenue growth and Goliath defence interest

Ilika CEO Graeme Purdy discusses Stereax product revenue, planned M300 battery deliveries, Goliath 10Ah development, EV market trends and rising demand from the defence sector.

Ilika plc reaches a commercial turning point as new markets emerge for Stereax and Goliath (video)

Dr Tom McColm of Morphose Capital Partners explains why the company may be approaching an important commercial inflection point.

Ilika plc: Stereax Revenue Arrives as Goliath Draws Defence Interest (video)

Ilika plc CEO Graeme Purdy outlines how Stereax has started generating product-related revenue, why M300 battery deliveries remain on track and how Goliath’s 10Ah prototype is opening new opportunities in defence and sovereign battery supply.

Ilika builds commercial momentum across Stereax and Goliath batteries

Ilika Plc reports annual results for the year ended 30 April 2026, highlighting progress on its Stereax medical battery line and Goliath large-format batteries for EV, defence and consumer applications. The company began Stereax production and deliveries, shipped larger Goliath prototypes, secured further grant funding and raised £5 million post-period to accelerate commercialisation.

Search